1. Caplan A, Fett N, Rosenbach M, et al. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects. J Am Acad Dermatol 2017;76:11-6.
https://doi.org/10.1016/j.jaad.2016.02.1239.
2. Kaltsas G, Makras P. Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy. Neuroendocrinology 2010;92:Suppl 1. 60-4.
https://doi.org/10.1159/000314298.
7. Swanson C, Lorentzon M, Conaway HH, et al. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinology 2006;147:3613-22.
https://doi.org/10.1210/en.2005-0717.
8. Sakr HF, Hussein AM, Eid EA, et al. Impact of dehydroepiandrosterone (DHEA) on bone mineral density and bone mineral content in a rat model of male hypogonadism. Vet Sci 2020;7:185.
https://doi.org/10.3390/vetsci7040185.
10. Redman LM, Ravussin E. Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal 2011;14:275-87.
https://doi.org/10.1089/ars.2010.3253.
12. Hu Y, Yang Y, Zhang M, et al. Intermittent fasting pretreatment prevents cognitive impairment in a rat model of chronic cerebral hypoperfusion. J Nutr 2017;147:1437-45.
https://doi.org/10.3945/jn.116.245613.
13. Hu Y, Zhang M, Chen Y, et al. Postoperative intermittent fasting prevents hippocampal oxidative stress and memory deficits in a rat model of chronic cerebral hypoperfusion. Eur J Nutr 2019;58:423-32.
https://doi.org/10.1007/s00394-018-1606-4.
14. Zhang J, Zhan Z, Li X, et al. Intermittent fasting protects against Alzheimer’s disease possible through restoring aquaporin-4 polarity. Front Mol Neurosci 2017;10:395.
https://doi.org/10.3389/fnmol.2017.00395.
15. Michalsen A, Li C. Fasting therapy for treating and preventing disease - current state of evidence. Forsch Komplementmed 2013;20:444-53.
https://doi.org/10.1159/000357765.
16. Bahijri SM, Ajabnoor GM, Borai A, et al. Effect of Ramadan fasting in Saudi Arabia on serum bone profile and immunoglobulins. Ther Adv Endocrinol Metab 2015;6:223-32.
https://doi.org/10.1177/2042018815594527.
17. Fraser WD, Logue FC, Christie JP, et al. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int 1998;8:121-6.
https://doi.org/10.1007/bf02672507.
19. Chen Z, Xue J, Shen T, et al. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. Int J Mol Med 2016;37:329-38.
https://doi.org/10.3892/ijmm.2015.2432.
20. Gotthardt JD, Verpeut JL, Yeomans BL, et al. Intermittent fasting promotes fat loss with lean mass retention, increased hypothalamic norepinephrine content, and increased neuropeptide Y gene expression in diet-induced obese male mice. Endocrinology 2016;157:679-91.
https://doi.org/10.1210/en.2015-1622.
21. Duan W, Guo Z, Jiang H, et al. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 2003;144:2446-53.
https://doi.org/10.1210/en.2002-0113.
22. Arum O, Saleh JK, Boparai RK, et al. Preservation of blood glucose homeostasis in slow-senescing somatotrophism-deficient mice subjected to intermittent fasting begun at middle or old age. Age (Dordr) 2014;36:9651.
https://doi.org/10.1007/s11357-014-9651-2.
25. Xu X, Ding J, Wu X, et al. Bone microstructure and metabolism changes under the combined intervention of ketogenic diet with intermittent fasting: an in vivo study of rats. Exp Anim 2019;68:371-80.
https://doi.org/10.1538/expanim.18-0084.
26. Barnosky A, Kroeger CM, Trepanowski JF, et al. Effect of alternate day fasting on markers of bone metabolism: An exploratory analysis of a 6-month randomized controlled trial. Nutr Healthy Aging 2017;4:255-63.
https://doi.org/10.3233/nha-170031.
28. Hofbauer LC, Gori F, Riggs BL, et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 1999;140:4382-9.
https://doi.org/10.1210/endo.140.10.7034.
29. Piemontese M, Xiong J, Fujiwara Y, et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. Am J Physiol Endocrinol Metab 2016;311:E587-93.
https://doi.org/10.1152/ajpendo.00219.2016.
30. Villareal DT, Shah K, Banks MR, et al. Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial. J Clin Endocrinol Metab 2008;93:2181-7.
https://doi.org/10.1210/jc.2007-1473.
31. Villareal DT, Fontana L, Das SK, et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: A randomized clinical trial. J Bone Miner Res 2016;31:40-51.
https://doi.org/10.1002/jbmr.2701.